At Sinopep, we are committed to advancing the frontiers of peptides, oligonucleotides, and small molecules as transformative therapeutic solutions. As a leader in pharmaceutical research, development, and manufacturing, we aim to set new standards across the industry. Our relentless focus on innovation, operational excellence, and scalable manufacturing has positioned us at the forefront of the global pharmaceutical landscape—delivering life-saving solutions and driving progress for our partners worldwide.

Sinopep is a trusted CDMO specializing in end-to-end CMC development and CGMP manufacturing of peptide and oligonucleotide APIs for NCEs, from early-phase development to commercialization.